Cibus welcomes EU move to treat non-transgenic gene-edited crops as conventional breeding

Cibus, Inc. Class A

Cibus, Inc. Class A

CBUS

0.00
  • Cibus welcomed new EU rules that treat crops improved without foreign DNA like conventionally bred crops, not transgenic GMOs.
  • The shift opens a regulatory pathway in Europe for Cibus’ non-transgenic gene-edited traits, supporting faster commercialization with seed partners.
  • Management framed the decision as science-based validation of its approach, citing potential to cut chemical use via traits such as disease resistance.
  • Cibus expects the EU move to influence other jurisdictions, building on progress in the UK, where it completed field trials in oilseed rape.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cibus Inc. published the original content used to generate this news brief on June 17, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.